Hook & thesis
Plains GP (PAGP) trades at roughly $28 today but is generating substantial free cash flow and sits at valuation multiples that look low for a midstream operator with stable fee-based cash flow. The combination of a near-term asset-sale driven deleveraging event and continued oil gathering and transportation growth in the Permian creates an asymmetric risk/reward: limited downside if the company reduces leverage materially, and meaningful upside if volumes and margin stability persist.
My trade: initiate a long position at $28 with a tight stop and a clear target tied to a multiple rerating and normalized cash generation. The setup is driven by three elements: (1) a completed or imminently closing NGL sale that frees cash to pay down debt and simplify the asset base, (2) free cash flow of roughly $2.34 billion supporting distributions and balance-sheet repair, and (3) valuation that implies a low multiple on normalized EBITDA.
What the company does and why investors should care
Plains GP Holdings is the publicly listed GP/holdings vehicle tied to Plains All American Pipeline, L.P., operating transportation, facilities and supply & logistics for crude oil, NGL and associated products. Investors care because midstream cash flows are largely fee-based and can be converted to cash via distributions, buybacks or debt reduction. For PAGP specifically, a sale of Canadian NGL assets was positioned to simplify the business into more of a pure-play crude midstream company - a profile that typically commands higher multiples than mixed NGL/storage portfolios when leverage comes down.
Support for the bullish case - the numbers
| Metric | Value |
|---|---|
| Current price | $28.00 |
| Market cap | $21.33B |
| Enterprise value | $12.92B |
| Free cash flow (trailing) | $2.343B |
| EV / EBITDA | 5.05x |
| PE | ~10x (EPS $2.80) |
| Price / FCF | ~2.37x |
| Debt / Equity | 5.34x |
| Most recent distribution (per share) | $0.4175 (per period) |
Two quick takeaways from the table: first, PAGP's free cash flow is large relative to enterprise value - FCF of ~$2.34B vs EV of ~$12.92B implies EV/FCF around ~5.5x. Second, traditional leverage metrics look elevated with a debt-to-equity ratio above 5x, which is the primary reason the market is attaching a low multiple to the business today.
How the story can change the multiple
The key to the valuation re-rate is balance-sheet repair. Management has flagged an intended close of the Canadian NGL sale to Keyera (timed to close in May 2026) and the proceeds from that transaction are earmarked to simplify the asset base and accelerate debt paydown. If the sale completes and the company channels material proceeds to reduce net debt, the EV/EBITDA multiple can re-rate toward peer midstream levels. Even a partial debt reduction from the sale materially improves the equity story because a lower debt burden increases distributable cash flow per unit and reduces perceived risk for yield-seeking investors.
Catalysts (timed and actionable)
- Completion of the Canadian NGL divestiture - the transaction was targeted for May 2026 and its closing or resolution of any regulatory hurdles is a direct lever on leverage and the equity multiple.
- Quarterly earnings and distribution announcements - maintenance or growth of the $0.4175 distribution signals stability; any distribution increases will attract income buyers.
- Permian throughput and utilization updates - rising crude volumes from the Permian translate into higher fee-based revenue across transportation and facilities.
- Debt-reduction announcements or repo/buyback programs - explicit allocation of sale proceeds to retire debt would be the clearest path to rerating.
Trade plan (actionable)
Entry: Buy at $28.00.
Stop-loss: $24.00 - a logical level that protects capital if regulatory setbacks, commodity weakness, or a distribution cut emerges.
Target: $36.00 - this reflects a rerating driven by balance-sheet repair and modest multiple expansion (about 29% upside from entry).
Horizon: long term (180 trading days). Expect deleveraging and balance-sheet improvements to unfold over multiple quarters; 180 trading days gives time for the asset-sale proceeds to be deployed, for a stabilization or increase in distributions, and for the market to re-appreciate a cleaner asset base.
This trade is calibrated to allow the transaction and its balance-sheet effects to work. If the sale is delayed or contested, the stop limits exposure while the target assumes partial multiple recovery rather than a near-term re-rating to peak multiples.
Valuation framing
At current levels the units trade at commoditized multiples: PE ~10x and EV/EBITDA ~5x. Those multiples are low relative to what a pure-play, lower-leverage crude midstream company typically commands. Importantly, free cash flow generation is strong: $2.343B of free cash flow versus an EV of $12.92B argues that the equity is cheap on a cash-generation basis. Put simply, the market is largely discounting the equity because of leverage and a mixed asset base; solve the leverage problem and the math supports a meaningful upside.
Risks and counterarguments
- Regulatory risk / transaction uncertainty: The Canadian NGL sale faced scrutiny from the Competition Bureau. If the transaction is delayed, materially altered, or blocked, the planned deleveraging pathway shrinks and the units could reprice lower.
- Commodity & volume risk: While much of midstream cash flow is fee-based, extreme declines in crude and NGL activity can reduce throughput volumes and spot-related revenue, pressuring cash flow and distributions.
- High reported leverage: Debt-to-equity sits above 5x. If management fails to retire debt or uses proceeds sub-optimally, the equity could remain discounted for an extended period.
- Distribution taxation and classification changes: Prior disclosures noted that a change in earnings and profits due to the asset sale could make parts of distributions taxable as dividends, altering the investor base and potentially reducing demand from tax-sensitive holders.
- Counterargument: The low multiples may be justified. The market could be pricing in not just leverage but also persistent NGL market weakness and lower-than-expected Permian throughput growth. If free cash flow normalizes lower than current trailing amounts, the valuation gap may persist or widen.
What would change my mind
I will reassess and likely reduce exposure if any of the following occur: (1) the NGL asset sale is definitively blocked or proceeds are significantly smaller than expected; (2) free cash flow falls consistently below ~$1.5B on a trailing basis; (3) management signals a distribution cut or pivots to uses of proceeds that do not reduce net leverage (for example, sustained large-scale acquisitions financed with debt); or (4) Permian volumes contract meaningfully quarter-to-quarter.
Conclusion
Plains GP presents an actionable long trade with defined risk controls. The core of the idea is straightforward: the company generates substantial free cash flow today, is positioned to simplify its asset base via a near-term sale, and can materially reduce leverage with proceeds. That combination should compress perceived risk and allow for multiple expansion from current levels. Use the $24 stop to limit downside and the $36 target to capture a conservative rerating while allowing 180 trading days for the balance-sheet work and operational cadence to play out.
Trade summary: Buy PAGP at $28.00, stop $24.00, target $36.00, horizon long term (180 trading days), risk medium.